Fever, cough, breathlessness, and fatigue were the most common symptoms of COVID-19 infection even 4 weeks after recovery and mean spirometric parameters and six-minute walk distance were reduced in patients with COVID-19 infection even 4 weeks after recovery.
Abstract
Introduction: COVID-19, caused by SARS-CoV-2, has affected millions worldwide, leading to significant acute and long-term health challenges. Post-COVID syndrome often includes persistent respiratory symptoms and reduced lung function, with limited data from Bangladesh on these sequelae.
Aim: This study aimed to assess socio-demographic, clinical, vaccination status, and lung function parameters in patients following COVID-19 infection and assess the effects of these parameters on post-COVID symptoms.
Methods: A cross-sectional study was conducted from August 2022 to July 2023 on 1,000 RT-PCR-confirmed COVID-19 recovered patients aged e”18 years in Gazipur, Bangladesh. Data on demographics, comorbidities, vaccination status, and clinical symptoms were collected through structured interviews. Lung function was assessed using spirometry (FEV1, FVC, FEV1/FVC), and the six-minute walk test (6MWD). Data analysis was performed using SPSS with descriptive and inferential statistics.
Results: The cohort was predominantly male (56.1%) and married (77.1%), with most patients aged >50 years. Underweight prevalence was high (38.1%), and 30.6% were current smokers. Hypertension (17.7%) and diabetes (10.2%) were the most common comorbidities. Common symptoms included fever (92.7%), cough (88.3%), breathlessness (53.6%), and fatigue (49.7%). Only 22.9% were fully vaccinated. Spirometry showed reduced lung volumes (mean FEV1: 1.78 L, FVC: 2.49 L) with a mean FEV1/FVC ratio of 77.26%. The 6MWD averaged 325.46 m, indicating impaired exercise capacity.
Conclusion: Fever, cough, breathlessness, and fatigue were the most common symptoms of COVID-19 infection. Mean spirometric parameters and six-minute walk distance were reduced in patients with COVID-19 infection even 4 weeks after recovery. The majority of respondents (72.8%) had received at least one dose of vaccination against COVID-19.
Chest Heart J. 2024; 48(2) : 83-89
Background: Post-coronavirus disease 2019 (COVID-19) condition, or long COVID, persists beyond the acute phase, impacting quality of life. This study estimated the incidence and determinants of post-COVID syndrome (PCS) in Puducherry, India. Methods: This ambispective cohort study from May to December 2022 included 116...
S. R. Renjana, M. Duraiswamy, V. Jayaseelan et al.· Indian Journal of Community...· 0 citations
Coronavirus disease 2019 (COVID-19) is an illness by the coronavirus that causes severe acute respiratory syndrome 2 (SARS-CoV-2), mainly impacting the lungs to different degrees. Investigation the symptoms of post-COVID-19 sequelae in patients aged ≥ 18 years, with pulmonary manifestations as interstitial lung disease...
Mohamed Saad Mohamed, Gehan Mohamed Elassal, Mohamed Rabiea Abdelghafar et al.· The Egyptian Journal of Inte...· 0 citations
ABSTRACT Background: Coronavirus disease 2019 (COVID19), caused by severe acute respiratory syndrome coronavirus 2, spreads rapidly and can cause severe acute respiratory failure; advanced age, chronic disease, and other comorbidities increase the risk of severe infection. By early 2022, more than 477 million cases and...
E. Urgecha, F. Tefera, Z. A. Alemu et al.· medRxiv· 0 citations
Background Severe COVID-19 is associated with immune dysregulation, microbiome disruption, and increased vulnerability to secondary infections. However, the longer-term risk of acute gastroenteritis (AGE) following COVID-19 remains poorly studied. We compared AGE incidence among community-managed and hospitalised COVID...
M. Hawkings, D. Hughes, A. J. Elliot et al.· medRxiv· 0 citations
Differences observed when including centers without systematic testing underscore the importance of considering testing strategies when evaluating the clinical impact of coinfections, and SARS-CoV-2 respiratory viral coinfections were not associated with increased COVID-19 severity.
C. di Chiara, Daniel S. Farrar, J. Bettinger et al.· The Pediatric Infectious Dis...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.